Page 157 - 《南京医科大学学报（自然科学版）》2026年第3期

第46卷第3期 王安倩，李心竹，周辰宇. 无创生物标志物与人工智能多模态整合技术在阿尔茨海默病早期诊断与
2026年3月 筛查中的研究进展［J］. 南京医科大学学报（自然科学版），2026，46（3）：457-465，474 ·465 ·

markers of Alzheimer’s disease as identified in saliva induces memory impairment by promoting ferroptosis in
using H NMR ⁃ based metabolomics［J］. J Alzheimer’s Dis， Alzheimer’s disease［J］. Cell Death Differ，2021，28（5）：
1
2017，58（2）：355-359 1548-1562
［34］RITCHIE C，SMAILAGIC N，NOEL⁃STORR A H，et al. ［47］PAN D，ZENG A，SONG X. Multiple patterns of structur⁃
CSF tau and the CSF tau/Abeta ratio for the diagnosis of al brain change trajectories in AD：MRI deep learning ver⁃
Alzheimer’s disease dementia and other dementias in ification with enhanced sequential pattern analysis［J］.
people with mild cognitive impairment（MCI）［J］. Co⁃ Alzheimer Dement，2023，19（Sup17）：2
chrane Database Syst Rev，2017，3（3）：CD010803 ［48］SGHIRRIPA S，BHALERAO G，GRIFFANTI L，et al.
［35］FRANÇOIS M，KARPE A，LIU J W，et al. Salivaomics as Evaluating traditional，deep learning and subfield meth⁃
a potential tool for predicting Alzheimer’s disease during ods for automatically segmenting the hippocampus from
the early stages of neurodegeneration［J］. J Alzheimers MRI［J］. Hum Brain Mapp，2025，46（5）：e70200
Dis，2021，82（3）：1301-1313 ［49］QIU S R，MILLER M I，JOSHI P S，et al. Multimodal deep
［36］GUO H Y，LI B，YAO H T，et al. Profiling the oral micro⁃ learning for Alzheimer’s disease dementia assessment［J］.
biomes in patients with Alzheimer’s disease［J］. Oral Nat Commun，2022，13：3404
Dis，2023，29（3）：1341-1355 ［50］NELSON P T，JICHA G A. Early hippocampal atrophy is
［37］BOUFTAS M. A systematic review on the feasibility of sali⁃ an important signal for clinicians but not necessarily a
vary biomarkers for Alzheimer’s disease［J］. J Prev Al⁃ harbinger of Alzheimer disease［J］. Neurology，2023，101
zheimers Dis，2021，8（1）：84-91 （24）：1087-1088
［38］CONTINI C，SERRAO S，MANCONI B，et al. Salivary pro⁃ ［51］FOWLER C J，STOOPS E，VANMECHELEN E，et al.
teomics reveals significant changes in relation to Alzhei⁃ Cross ⁃ sectional investigation of synaptic markers neuro⁃
mer’s disease and aging［J］. J Alzheimers Dis，2022，89 granin and BACE1 in CSF from the AIBL study［J］. Al⁃
（2）：605-622 zheimers Dement，2023，19（S14）：e078048
［39］PUKHALSKAIA A E，DYATLOVA A S，LINKOVA N S， ［52］MENENDEZ ⁃ GONZALEZ M. Implementing a tridimen⁃
et al. Sirtuins as possible predictors of aging and Alzheim⁃ sional diagnostic framework for personalized medicine in
er’s disease development：verification in the hippocam⁃ neurodegenerative diseases［J］. Alzheimers Dement，
pus and saliva［J］. Bull Exp Biol Med，2020，169（6）： 2025，21（2）：e14591
821-824 ［53］PELKMANS W，SHEKARI M，BRUGULAT⁃SERRAT A，
［40］JIAO L L，DONG H L，LIU M M，et al. The potential roles et al. Astrocyte biomarkers GFAP and YKL⁃ 40 mediate
of salivary biomarkers in neurodegenerative diseases［J］. early Alzheimer’s disease progression［J］. Alzheimers De⁃
Neurobiol Dis，2024，193：106442 ment，2024，20（1）：483-493
［41］PAN D，ZENG A，YANG B Y，et al. Deep learning for ［54］WOJDAŁA A L，BELLOMO G，GAETANI L，et al. Trajec⁃
brain MRI confirms patterned pathological progression in tories of CSF and plasma biomarkers across Alzheimer’s
Alzheimer’s disease［J］. Adv Sci，2023，10（6）：2204717 disease continuum：disease staging by NF⁃L，p⁃tau181，
［42］XHIMA K，OTTOY J，GIBSON E，et al. Distinct spatial and GFAP［J］. Neurobiol Dis，2023，189：106356
contributions of amyloid pathology and cerebral small ves⁃ ［55］HANNAH S，ANDREAS N，LAURA P，et al. Prediction
sel disease to hippocampal morphology［J］. Alzheimers of Alzheimer’s disease diagnosis within 14 years through
Dement，2024，20（5）：3687-3695 Aβ misfolding in blood plasma compared to APOE4 sta⁃
［43］FRIZZELL T O，GLASHUTTER M，LIU C C，et al. Artifi⁃ tus ，and other risk factors［J］. Alzheimers Dement，
cial intelligence in brain MRI analysis of Alzheimer’s dis⁃ 2020，16（2）：16
ease over the past 12 years：a systematic review［J］. Age⁃ ［56］ALTY J，BAI Q，LI R J，et al. The TAS Test project：a pro⁃
ing Res Rev，2022，77：101614 spective longitudinal validation of new online motor⁃cogni⁃
［44］LEE J，BURKETT B J，MIN H K，et al. Deep learning⁃ tive tests to detect preclinical Alzheimer’s disease and es⁃
based brain age prediction in normal aging and demen⁃ timate 5⁃year risks of cognitive decline and dementia［J］.
tia［J］. Nat Aging，2022，2（5）：412-424 BMC Neurol，2022，22（1）：266
［45］JOSEPHS K A，MARTIN P R，WEIGAND S D，et al. Pro⁃ ［57］ASHTON N J，PUIG⁃PIJOAN A，MILÀ⁃ALOMÀ M，et al.
tein contributions to brain atrophy acceleration in Al⁃ Plasma and CSF biomarkers in a memory clinic：head⁃to⁃
zheimer’s disease and primary age⁃related tauopathy［J］. head comparison of phosphorylated tau immunoassays［J］.
Brain，2020，143（11）：3463-3476 Alzheimers Dement，2023，19（5）：1913-1924
［46］BAO W D，PANG P，ZHOU X T，et al. Loss of ferroportin （下转第474页）